Duchenne Muscular Dystrophy Registry Study
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study tracks the natural history of Duchenne Muscular Dystrophy over time. It collects information from patients at four centers to better understand how the disease progresses, which may help improve care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Duchenne Muscular Dystrophy, confirmed by a genetic test.
- You are being followed at one of the four study centers (all in Italy).
- You can give your permission (sign an informed consent form) to join the registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Duchenne muscular dystrophy (a muscle-weakening condition) to track how the disease progresses over time. By collecting this data, researchers hope to better understand the condition and improve future care.
This study follows boys with Duchenne muscular dystrophy over time to better understand how the condition changes and how standard treatments affect health and function. It does not appear to test a new medicine, but it may help doctors plan better future care and studies.
This is a research study that follows people with Duchenne muscular dystrophy and female genetic carriers to better understand the condition. It may help researchers measure health patterns over time, which can support future treatments.
This registry collects information about people with Duchenne or Becker muscular dystrophy, including women who carry the gene (with or without symptoms). It may help researchers better understand the condition and plan future studies.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study follows people with Duchenne muscular dystrophy (DMD) who are taking eteplirsen, golodirsen, or casimersen. It aims to understand how these medicines work in everyday life over a long period.
Hear when a new Duchenne Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.